Immunization

The report references adult vaccines, in terms of volume of use, for influenza, diphtheria and tetanus (Td), diphtheria, tetanus and pertussis (TDaP), hepatitis B, herpes zoster and pneumococcal.

By educating patients and administering vaccinations, these key health care providers can help prevent new cases from occurring.

A Western Australian study found the influenza vaccine has a possible protective effect against hospitalization for respiratory syncytial virus (RSV).

Heterologous vaccination—or mixing different vaccines—was safe and effective with Novavax and provided enhanced protection against the Omicron variant, a new study found.

The first RSV vaccines were approved by the FDA earlier this year.

A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.

The VRBPAC committee voted 21-0 in favor of this recommendation.

Abrysvo is the second RSV vaccine approved by the FDA.

New data from Digestive Disease Week furthers evidence that biologics can be effective

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

Unvaccinated patients who were older at MG onset and at SARS-CoV-2 infection had more severe cases.

The Ghana Food and Drugs Authority approved R21 for children aged five months to three years.

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.

Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.

Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.

Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.

HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.

Vaccine hesitancy exists on a spectrum, but with the right tools, pharmacists can provide education and reassurance to parents and caregivers.

Project NextGen will focus on the development of vaccines and long-lasting monoclonal antibody COVID-19 treatments.

Researchers of a new study investigated what's causing vaccine hesitancy, and why individuals are feeling vaccine fatigue.

Though unlikely to pass this year, opponents say the proposal is nonetheless amplifying the spread of false claims and sowing distrust of medical professionals.

From variants to vaccines, much has changed in the COVID-19 landscape.

Investigators found a robust antigen-specific antibody response against HIV and Zika virus between mothers and newborns in a model using rabbits.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

The 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.

Attitudes, behaviors, and barriers to immunizations are examples of themes that affect perceptions of childhood vaccines.